LeonaBio (LONA) Retained Earnings (2019 - 2026)
LeonaBio (LONA) reported Retained Earnings of -$13000.0 for Q1 2026, down 225.0% year-over-year from $10400.0 in Q1 2025, and down 225.0% on a QoQ basis from -$4000.0 in Q4 2025.
LeonaBio (LONA) has 8 years of Retained Earnings data on file, last reported at -$13000.0 in Q1 2026.
- Quarterly Retained Earnings fell 225.0% year-over-year to -$13000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13000.0 (down 225.0% YoY) and the FY2025 annual result came in at -$4000.0, up 100.0% from the prior year.
- Retained Earnings declined to -$13000.0 in Q1 2026 per LONA's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at -$3000.0 in Q2 2025 and bottomed at -$428.9 million in Q3 2025.
- The 5-year median for Retained Earnings is -$116.9 million (2022), against an average of -$162.8 million.
- The widest annual swing landed in 2022, when Retained Earnings sank 61900.0%; it then jumped 100.0% in 2025.
- Tracing LONA's Retained Earnings over 5 years: stood at -$191.5 million in 2022, then sank by 61.44% to -$309.2 million in 2023, then plunged by 31.35% to -$406.1 million in 2024, then jumped by 100.0% to -$4000.0 in 2025, then slumped by 225.0% to -$13000.0 in 2026.
- Per Business Quant, the three latest LONA Retained Earnings figures stand at -$13000.0 (Q1 2026), -$4000.0 (Q4 2025), and -$428.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -24.89 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | -13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -4,000.00 |
| Sep 30, 2025 | -428.87 Mn |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -406.15 Mn |
| Sep 30, 2024 | -391.14 Mn |
| Jun 30, 2024 | -362.40 Mn |
| Mar 31, 2024 | -335.54 Mn |
| Dec 31, 2023 | -309.21 Mn |
| Sep 30, 2023 | -678,000.00 |
| Jun 30, 2023 | -939,000.00 |
| Mar 31, 2023 | -219.35 Mn |
| Dec 31, 2022 | -191.53 Mn |
| Sep 30, 2022 | -2.47 Mn |
| Jun 30, 2022 | -1.93 Mn |
| Mar 31, 2022 | -116.88 Mn |
| Dec 31, 2021 | -388,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 37,000.00 |
| Mar 31, 2021 | -49.91 Mn |
| Dec 31, 2020 | -41.04 Mn |
| Sep 30, 2020 | 7,000.00 |
| Dec 31, 2019 | -21.09 Mn |